Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | DHFR | P00374 | 7/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3660582 | 0.96 | PPARA (0.45) | PPARAEPHX2FAAHCNR1TSHR | |
| SCHEMBL3657459 | 0.91 | MAOB (0.43) | PPARAEPHX2FAAHCNR1TSHR | |
| SCHEMBL3770972 | 0.87 | PPARA (0.42) | PPARATSHRKDM4EALDH1A1MAOB | |
| SCHEMBL3770838 | 0.87 | PPARA (0.48) | PPARATSHRKDM4EALDH1A1MAOB | |
| SCHEMBL3764400 | 0.86 | PPARA (0.44) | PPARATSHRKDM4EALDH1A1MAOB | |
| SCHEMBL3764368 | 0.86 | PPARA (0.50) | PPARATSHRMAOBDHFRGGPS1 | |
| SCHEMBL3770884 | 0.82 | MAOB (0.43) | PPARATSHRKDM4EALDH1A1MAOB | |
| SCHEMBL3775414 | 0.82 | MAOB (0.43) | PPARATSHRKDM4EALDH1A1MAOB | |
| SCHEMBL3769194 | 0.82 | AOC3 (0.46) | MAOB | |
| SCHEMBL3764504 | 0.82 | PPARA (0.55) | PPARAEPHX2FAAHTSHRMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | PPARA 1791/4885EPHX2 2984/4885FAAH 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.